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Background: Tumour size in breast cancer influences therapeutic decisions. The purpose of this study was to
evaluate sizing of primary breast cancer using mammography, sonography and magnetic resonance imaging (MRI)
and thereby establish which imaging method most accurately corresponds with the size of the histological result.
Methods: Data from 121 patients with primary breast cancer were analysed in a retrospective study. The results
were divided into the groups “ductal carcinoma in situ (DCIS)”, invasive ductal carcinoma (IDC) + ductal carcinoma
in situ (DCIS)”, “invasive ductal carcinoma (IDC)”, “invasive lobular carcinoma (ILC)” and “other tumours” (tubular,
medullary, mucinous and papillary breast cancer). The largest tumour diameter was chosen as the sizing reference
in each case. Bland-Altman analysis was used to determine to what extent the imaging tumour size correlated with
the histopathological tumour sizes.
Results: Tumour size was found to be significantly underestimated with sonography, especially for the tumour
groups IDC + DCIS, IDC and ILC. The greatest difference between sonographic sizing and actual histological tumour
size was found with invasive lobular breast cancer. There was no significant difference between mammographic
and histological sizing. MRI overestimated non-significantly the tumour size and is superior to the other imaging
techniques in sizing of IDC + DCIS and ILC.
Conclusions: The histological subtype should be included in imaging interpretation for planning surgery in order
to estimate the histological tumour size as accurately as possible.
Keywords: Breast cancer, Tumour size, Sonography, Mammography, Magnetic resonance imaging, Ductal
carcinoma in situ, Invasive ductal carcinoma, Invasive lobular carcinomaBackground
The key importance of imaging methods in breast diag-
nostics lies in the detection and sizing of areas suspi-
cious for malignancy. Breast results are classified using
the BI-RADS (Breast Imaging Reporting and Data Sys-
tem) classification [1,2].
Exact pre-therapeutic tumour sizing using imaging
methods plays a central role. For example, the possibility* Correspondence: Markus.Hahn@med.uni-tuebingen.de
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reproduction in any medium, provided the orof breast conserving treatment significantly depends on
the relationship between the tumour-to-breast size. Fur-
thermore, the indication for primary systemic treatment
is made, amongst other things, from the tumour size.
The aim of this study was to analyse which of the
given imaging methods is the most accurate in the pre-
therapeutic sizing of primary breast cancer.Methods
121 patients with primary breast cancer who presented
preoperatively in the University Breast Centre of
Tuebingen between June 2005 and July 2007 wereLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing criteria: primary breast cancer, no neoadjuvant
chemotherapy, complete documentation of the tumour
size from mammography, sonography and magnetic res-
onance imaging (MRI) as well as the postoperative histo-
logical tumour size. The largest tumour diameter was
chosen as the sizing reference in each case.
Diagnostic imaging equipment
Mammography was performed using two digital full
field instruments (Senographe 2000 D, GE Healthcare,
Munich, Germany; Selenia, Hologic GmbH, Frankfurt
am Main, Germany).
Sonography was performed using a linear transducer
with a 50 mm width and a frequency of 12 MHz. Models
iU22 and HD 11 from Philips (Philips GmbH Healthcare,
Hamburg, Germany) were used. The examination was car-
ried out using “Spatial Compound Imaging” and “XRES
Adaptive Image Processing”. Measurement of tumor size
took the echopoor centre of the lesion and the echogenic
halo into account. The clinical examiner held a minimum
of the Degum Level 2 qualification.
Magnetic resonance imaging (MRI) was performed
using a 1.5 Telsa system (Gyroscan Achieva, Philips
GmbH Healthcare, Hamburg, Germany). A T1-weighted
dynamic gradient echo sequence (T1w-FFE = Fast Field
Echo) with a native and 7 post-contrast medium series
was used. Automated bolus injection of 0.16 mmmol
Gadobutrol per kg body weight followed by 10 ml saline
were infused intravenously. Image post-processing in-
cluded the generation of subtraction series and recon-
struction of a MIP (maximum intensity projection).
Imaging analysis was carried out using the digital data
with the help of a suitable workstation (View Forum,
Philips Healthcare, Hamburg, Germany).
Only physicians who were specialized on breast diag-
nostics performed and reviewed each imaging.
Statististical evaluation
The histological results were divided into the groups
“ductal carcinoma in situ (DCIS)”, “invasive ductal
carcinoma (IDC) + ductal carcinoma in situ (DCIS)”,
“invasive ductal carcinoma (IDC)”, “invasive lobular car-
cinoma (ILC)“ and “other tumours” (tubular, medullary,
mucinous und papillary breast cancer). The largest
tumour diameter was chosen as the sizing reference in
each case. Bland-Altman analysis was used to determine
to what extent the imaging tumour size correlated with
the histopathological tumour sizes.The mean difference
between the imaging and the histological results was cal-
culated and related to the interval in which 95% of the
calculated differences were found (LOA = limits of
agreement). Size variation on imaging versus pathology
were reported as median and interquartile range, usingBox plots. The statistical analysis was performed using
SPSS® for Windows (Version 15.0; IBM, Chicago). The
level of significance was defined as a p-value of <0.05.
There was no objection against the study from the
local ethic committee.
Results
Patient collective and malignancy assessment using
imaging
121 patients with primary breast cancer were evaluated
in a retrospective analysis. The median age was 57 years
(range 35–92). An IDC was present in 33.9% of the
cases. 31.4% of the patients were allocated to the IDC +
DCIS tumour group, and a DCIS alone or ILC alone
were found in 12.4% and 14.9% respectively. “Other tu-
mours” occurred in 7.4% of the cases.
The density level of the breast tissue was graded using
mammography according to the American College of
Radiology (ACR) [1] classification system. In doing so,
8.3% exhibited predominantly lipomatous glandular tissue
(ACR I). A mammographic density grade II was present in
29.8% and a density grade III in 47.9%. 13.2% of women
had very dense glandular tissue (ACR IV). Density grading
was not carried out in one case (0.8%). Malignancy assess-
ment using imaging was performed according to the
BI-RADS classification system [1], whereby 96.6% of the
sonographic results, 90.9% of the mammography results
and 100% of the MRI results were pre-interventionally
classified as BI-RADS 4 or higher (Table 1).
Comparison of histological sizing with the sizing
indication from sonography, mammography and MRI
As demonstrated in Table 2, there was a mean difference
between the sonographic and histological sizing of
-8 mm (LOA: -43 to 28 mm). The median difference
was -2 mm (interquartile range: -10 to 1 mm, Figure 1).
In the total sonographic collective, there was a highly
significant underestimation of tumour size (Table 2),
which can be particularly seen in histologically larger
lesions (Figure 2). Based on the individual tumour
groups, a significant underestimation of size was
detected for IDC + DCIS, IDC and ILC (Table 2).
The mean difference between mammography and hist-
ology was -1 mm (LOA: -36 to 34 mm, Table 2). The
median difference was 0 mm (interquartile range: -5 to
4 mm, Figure 1). There was a non-significant underesti-
mation of size in the whole collective (Figure 3) with no
significance based on the individual tumour groups
(Table 2).
Using MRI, the mean difference in sizing, as compared
to the histological tumour size, was found to be 2 mm
(LOA: -34 to 39 mm, Table 2). The median difference was
2 mm (interquartile range: -1 to 7 mm, Figure 1), which
corresponded with a non-significant size overestimation in
Table 1 Correlation between the BI-RADS classification (Breast Imaging Reporting and Data System) and the histology
for the corresponding imaging method
BI-RADS classification Isolated DCIS IDC-DCIS Isolated-IDC Isolated ILC Other tumours Total
Diagnostic imaging N (%) N (%) N (%) N (%) N (%) N (%)
Sonography 0 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
1 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
2 0 (0%) 0 (0%) 0 (%) 0 (0%) 1 (11.1%) 1 (0.8%)
3 0 (0%) 0 (0%) 3 (7.3%) 0 (0%) 0 (0%) 3 (2.5%)
4 10 (66.7%) 17 (44.8%) 10 (24.4%) 8 (44.4%) 5 (55.6%) 50 (41.3%)
5 5 (33.3%) 20 (52.6%) 28 (68.3%) 10 (55.6%) 3 (33.3%) 66 (54.5%)
6 0 (0%) 1 (2.6%) 0 (0%) 0 (0%) 0 (0%) 1 (0.8%)
Mammography 0 0 (0%) 1 (2.6%) 0 (0%) 1 (5.6%) 0 (0%) 2 (1.7%)
1 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
2 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
3 1 (6.7%) 4 (10.5%) 3 (7.3%) 0 (0%) 1 (11.1%) 9 (7.4%)
4 1 (6.7%) 12 (31.6%) 17 (41.5%) 11 (61.1%) 5 (55.6%) 46 (38.0%)
5 13 (86.6%) 19 (50%) 17 (41.5) 6 (33.3%) 3 (33.3%) 58 (47.9%)
6 0 (0%) 2 (5.3%) 4 (9.7%) 0 (0%) 0 (0%) 6 (5.0%)
MRI 0 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
1 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
2 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
3 0 (0%) 0 (0%) 0 (0%) 0 (%) 0 (0%) 0 (0%)
4 0 (0%) 2 (5.3%) 4 (9.8%) 0 (0%) 0 (0%) 7 (5.8%)
5 9 (60%) 22 (57.9%) 26 (63.4%) 8 (44.4%) 3 (33.3%) 68 (56.2%)
6 6 (40%) 14 (36.8%) 11 (26.8%) 9 (50%) 6 (66.7%) 46 (38.0%)
DCIS Ductal carcinoma in situ, IDC Invasive ductal carcinoma, ILC Invasive lobular carcinoma.
Gruber et al. BMC Cancer 2013, 13:328 Page 3 of 8
http://www.biomedcentral.com/1471-2407/13/328the whole collective (Figure 4). No significant correlations
were found within the individual tumour groups (Table 2).
Discussion
Breast lesion sizing by ultrasound imaging,
mammography and MRI in comparison to
histopathological sizing
This retrospective analysis showed a highly significant




Sonography and histology Mamm
M (mm) LOA (mm) r M (mm)
DCIS −15 −87 to 56 0,304 −1
IDC - DCIS −9* −47 to 30 0,570 −4
IDC −4* −20 to 13 0,853 3
ILC −10** −31 to 11 0,853 1
Other tumours −1 −9 to 6 0,907 3
TOTAL −8** −43 to 28 0,525 −1
Significant differences *p < 0,05 **p < 0,001.
DCIS Ductal carcinoma in situ, IDC Invasive ductal carcinoma, ILC Invasive lobular cawith sonography (Table 2; p < 0,001), with a mean of
8 mm. This underestimation increased as the histo-
logical result size increased (Figure 2). The investigations
by Hieken et al. [3], Shoma et al. [4] and Bosch et al. [5]
confirmed the sonographic underestimation of the histo-
logical tumour size. Hieken et al. [3] attributed this to
the unclear margins of sonographic results from exten-
sive intraductal in-situ components. Bosch et al. [5]
linked the underestimation with tumour size, with thetumour size
ifference between
ography and histology MRI and histology
LOA (mm) r M (mm) LOA (mm) r
−71 to 68 0,374 5 −46 to 56 0,744
−43 to 35 0,502 2 −46 to 49 0,311
−16 to 22 0,821 3 −19 to 26 0,732
−20 to 13 0,821 2 −31 to 34 0,732
−8 to 14 0,867 −2 −14 to 10 0,752
−36 to 34 0,550 2 −34 to 39 0,554
rcinoma, M mean, LOA limits of agreement, r - correlation coefficient.
Figure 1 Box Plots illustrating the median size difference
between imaging (sonography, mammography and MRI) and
histology and the corresponding interquartile range with
whiskers from the 5th to the 95th percentile.
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the transducer. An alternative technique here would be
the panorama mode. This technique allows a complete
image to be built from individual sectional sonographic
images. The sonographic measurement of masses whose
diameters exceed the width of the transducer is thereby
made more accurate.
With regard to mammography, our data also show an
underestimation of the mean histological result ofFigure 2 Bland Altman Plots illustrating the size difference between s
tumour size.1 mm, although this was not found to be significant
(Table 2). The study by Hieken et al. [3] also showed a
size underestimation with mammography, which was at-
tributed to the high compression of the breast during
the examination. Furthermore, the mammographic size
estimation is also negatively affected by breast density.
A non-significant size overestimation of 2 mm in the
whole collective was found according to our analysis of
the MRI results (Table 2). Onesti et al. [6] described a
significant MRI mean overestimation of 1.06 cm, espe-
cially for results of >2 cm in size. This can be traced
back to tumours with larger DCIS-components or a
higher proportion of fibrotic tissue.
Studies which comparatively analysed the diagnostic
measurement accuracy of mammography, sonography
and MRI came to the conclusion that MRI offered the
best correlation with the histological tumour size [7-9].
For a mean histological tumour size of 2.76 cm, Wasif
et al. [7] identified a mean tumour site of 2.1 cm using
mammography, 1.73 cm using sonography and 2.65 cm
with MRI. In a study by Boetes et al. [9] the tumour size
with mammography and sonography was underestima-
ted in 14% and 18% of the results respectively, whereas
MRI did not show any significant deviation from the
histological sizing.
Significant underestimation of the histological sizing with
ultrasound depending on the tumour type
Out data showed a significant underestimation of the
histological size with ultrasound with regard to theonography and histology compared to the histological
Figure 3 Bland Altman Plots illustrating the size difference between mammography and histology compared to the histological
tumour size.
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and ILC (p = 0.001). The greatest mean difference be-
tween the sonographically measured tumour size and
the actual histological tumour size was found for inva-
sive lobular breast cancer (Table 2). Pritt et al. [10] also
described the greatest sonographic size underestimationFigure 4 Bland Altman Plots illustrating the size difference between Mfor ILC compared to IDC or ILC-IDC, with a median of
7.5 mm. Our analysis gave a mean size underestimation
of 10 mm in this group. Diagnostic demarcation of the
tumour using imaging is made more difficult because of
the diffuse, infiltrative growth pattern of ILC [11]. Fur-
thermore, ILC tends towards multifocality because ofRI and histology compared to the histological tumour size.
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itional use of MRI for surgical planning is justifiable, as
shown by Rodenko GN et al. [12].
No significant differences between tumour types and
histologically established tumour sizes could be found in
our study for mammography and for MRI.
Influencing factors of imaging
In contrast to sonography and MRI, the sensitivity of
mammography is significantly negatively affected by in-
creasing breast tissue density [13-15]. Mammographic
sensitivity is therefore 30-48% for ACR IV dense glandu-
lar breast tissue [13,15] , and mostly breast cancer can
only be inadequately displayed with this technique
(occult). Breast density also influences the exact sizing of
tumours. According to the inclusion criteria definition
of our study, results were only included which were vis-
ible by all three imaging techniques (mammography,
sonography and MRI). Overall, there were no significant
variations from the histological tumour size for mam-
mography (Table 2).
If imaging malignancy assessment with reference to
the individual tumour groups is considered, isolated
DCIS is clearly more commonly classified as BIRADS 5
(Table 1) with mammography (86.8%) than with sonog-
raphy (33.3%) in our analysis, despite predominantly oc-
curring (66.6%) in ACR III-IV density glandular breast
tissue. This is due to the fact that DCIS is accompanied
by typical suspicious microcalcification in 73 – 98%,
which can be identified mammographically independ-
ently of the density of the glandular breast tissue
[16-18]. Microcalcification is inadequately seen with
ultrasound [19-21]. Soo et al. [21] demonstrated that
sonographically conspicious lesions were only detected
in 23% of mammographically conspicious microcalcifica-
tons. An exact measurement of the extent of microcal-
cification is not possible with sonography.
When considering ILC, the detection of clinical find-
ings must be regarded as separate from sizing. In a study
by Butler et al. [22], 39% of the mammographically oc-
cult ILC and 88% of ILC were diagnosed using ultra-
sound. In our assessment, ILC was present in 14.9% of
all tumours. ILC was diagnosed as BI-RADS 5 in 55%
with sonography and as BI-RADS 5 in 33.3% using
mammography. Ultrasound therefore appears to be
superior to mammography in the detection of ILC,
whereas mammography can more accurately determine
the size than ultrasound.
Sizing of ILC using sonography reveals a significant
underestimation of tumour size compared to mammog-
raphy (Table 2). In this context, a sonographic influen-
cing factor can be the varying individual interpretation
of the malignancy criteria by the various clinicians. For
example, the clinical finding size varies depending onwhether the hyperechoic margin of a tumour is included
or not. In a retrospective analysis, it is always important
to question whether all clinicians have interpreted the
malignancy criteria in the same way [23,24]. Further ma-
lignancy criteria which could result in differing interpret-
ation of the tumour size are the dorsal acoustic
attenuation, the blurred margin and as well as infiltra-
tion of the vessels in Doppler sonography [25,26].
Although sonoelastography presents with a lower
interobserver variability than conventinal B-mode im-
aging, Isermann et al. [27] found no significant advan-
tage in breast lesion sizing of this technique.
Modern ultrasound equipment also usually operates
with complex image processing software. A danger of
the image processing is that clinical findings are modi-
fied or so embellished that the interpretation of the clas-
sical malignancy criteria done up to now is no longer
possible [28]. This could also lead to anomalies in the
sizing of focal findings.
In contrast to mammography and sonography, all
tumours were correctly preoperatively classified as re-
quiring further clarification (> BI-RADS IV) with MRI,
(Table 1), and 38% of cases were already histologically
confirmed (BI-RADS 6). With regard to sizing, there is a
non-significant overestimation of size with MRI in all
tumour groups. Analogous to our data, other studies
[29-32] show that MRI is superior to both mammog-
raphy and sonography in the diagnosis of DCIS and ILC.
In a study by Kuhl et al. [30], MRI showed sensitivity for
all DCIS cases, whether with or without microcalcifi-
cation, of 98%. For mammography, which relies on the
interpretation of suspicious microcalcification and there-
fore does not detect all DCIS cases, the sensitivity was
only 52% [30]. Berg et al. [29] could also show that MRI
exhibited a sensitivity of 89% compared to 55% sensitiv-
ity for mammography and 47% for ultrasound.Study limitations
Investigator influence during the malignancy assessment
of the results due to previous knowledge of the results
of other imaging techniques cannot be excluded. 38% of
the MRI results were BI-RADS 6-lesions and were there-
fore histologically confirmed first of all. However, this
study considered sizing and not malignancy assessment;
therefore this does not appear to have any influence on
the results. Moreover study population was retrospect-
ively analysed and limited to only those patients with
cancer visible on all three imaging modalities.Conclusions
According the data from this study (see Table 2), the
following points should be observed for the implementa-
tion of valid breast cancer sizing:
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methods; MRI and mammography are the more
exact methods, whilst sonography showed a
significant underestimation of the results.
2. IDC with extensive DCIS involvement can be most
accurately measured with MRI. Ultrasound leads to
a significant size underestimation on average.
3. According to our data, DCIS alone can be most
accurately measured using mammography.
Mammography and MRI show no significant
variations from the mean tumour size compared to
histology.
4. ILC is measured most accurately using MRI and
mammography, provided that the results are visible
with mammography. Sonography leads to a
significant underestimation of the mean tumour size.
From these results, we conclude that for surgical plan-
ning, the histological subtype should be included in the
imaging interpretation in order to estimate the tumour
size as accurately as possible.
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